font size
printPrint


Policy

Subtopics:

REGULATORY:

Let Them Have Their Say

Patients should have access to information from every source including drugmakers.


Almost two-years to the day, the controversial EU-wide ban on drug advertising may soon end—although what this means, precisely, is unclear. The European commission plans to allow drug companies to give “information” about their drugs to the public on TV, the Internet and in print. Peter Pitts, president of the Center for Medicine in the Public Interest, offers some thoughts on the controversy.

READ MORE.

 

  • Critical Condition
    Trustees warn that new taxes or significant service cuts are needed to make Medicare sustainable.
    March 27, 2008 - Policy - Healthcare Reform
  • Lost Generation
    Harvard University's Kevin Casey talks about how a stagnant NIH budget threatens to send young researchers searching for new careers.
    March 21, 2008 - Policy - Research
  • Measure for Measure
    Health technology assessment must use a patient-centric model if it is to be more than a political tool to cut cost and reduce care.
    March 17, 2008 - PETER J. PITTS - Policy - Healthcare Reform
  • The Best Column You've Ever Read
    Research shows expectations are important, after findings that a placebo work better when patients think it's an expensive drug.
    March 12, 2008 - DANIEL S. LEVINE - Policy - Healthcare Reform
  • PODCAST: March 2008
    Turn On, Tune In, and Research.
    March 07, 2008 - Policy - Research
  • A Healthcare GPS for Doctors    
    Evidence-based medicine could help physicians navigate the complexities of patient care by collecting, interpreting, and disseminating data on outcomes.
    March 04, 2008 - DAVID GOLLAHER - Policy - Healthcare Reform
  • Sick and Busted
    Universal coverage could still leave people vulnerable to bankruptcy unless coverage is more comprehensive than existing policies, study warns.
    February 08, 2008 - Policy - Healthcare Reform
  • Naughty or NICE?    
    The U.K.'s National Institute for Health and Clinical Excellence could be a model for the U.S. healthcare system, but critics say the agency stifles innovation and limits access.
    February 04, 2008 - HELEN JOYCE - Policy - Regulatory
  • PODCAST: February 2008
    February 01, 2008 - Policy - Regulatory
  • Fools on the Hill
    Politics triumphs over public health as a spending package blocks funding for newly-created foundation to advance drug development.
    December 26, 2007 - PETER J. PITTS and ROBERT GOLDBERG - Policy - Regulatory
  • Inspecting the Inspectors
    GAO finds weaknesses in FDA's program for inspecting foreign drug manufacturers.
    November 28, 2007 - Policy - Regulatory
  • Influential People    
    A study on cancer survival rates sparks questions of industry funding of research.
    November 02, 2007 - ERIKA STALDER - Policy - Research
  • Critical Wrath
    The FDA should not be chastised, but applauded for working with industry to tackle the big problems of drug development.
    October 16, 2007 - PETER PITTS - Policy - Regulatory
  • Get the NIH Back on Track
    The President's projected NIH budget for 2008 of $28.3 billion will result in a net reduction of almost $500 million for research funding.
    October 03, 2007 - Greg Lucier and Joe Panetta - Policy - Research
  • California, Here We Come    
    Other U.S. states have no intention of being left in the dust despite the Golden State's big lead in stem cell research funding.
    October 01, 2007 - MICHAEL J. WERNER - Policy - Regenerative Medicine
  • Finding the Right Balance    
    Publisher's Letter
    October 01, 2007 - DAVID GOLLAHER AND G. STEVEN BURRILL - Policy - Research
  • Pushing Drugs    
    Big pharma would love to see more countries allow direct advertising.
    October 01, 2007 - BETTE FLAGLER - Policy - Regulatory
  • Bad Medicine
    To cut healthcare costs, we need to focus on early treatment of chronic conditions, rather than force patients to switch to generic alternatives that may not be equivalent to the medicines they are using.
    September 25, 2007 - PETER PITTS - Policy - Regulatory
  • Genetic Discrimination
    American's don't want to share information about their DNA with just anyone.
    September 10, 2007 - Policy - Regulatory
  • Uncovering the Potential    
    September 01, 2007 - By David Gollaher - Policy - Regenerative Medicine
  • Why the Controversy Misses the Point    
    A focus on embryos and cures has obscured an invaluable research tool.
    September 01, 2007 - By Gareth Cook - Policy - Regulatory
  • The California Experiment    
    The state's $3-billion voter initiative to fund stem cell research has democratized science, but in doing so has also created something
    September 01, 2007 - By David Gollaher - Policy - Regenerative Medicine
  • Healthy Debates    
    Elias A. Zerhouni discusses the NIH's tightened budget and what that might mean for the next generation of scientists.
    September 01, 2007 - Policy - Research
  • Amgen Feeling Anemic
    Reimbursement restrictions could trigger a wallop from private payers.
    August 06, 2007 - DANIEL S. LEVINE - Policy - Regulatory
  • Phoning It In
    The FDA needs to rethink the way it communicates in an age of empowered patients.
    August 01, 2007 - PETER PITTS - Policy - Regulatory
  • FDA Thinks Small
    Agency task force wrestles with the regulatory challenges posed by nanotechnology, but critics say its business as usual.
    July 27, 2007 - DANIEL S. LEVINE - Policy - Regulatory
  • Revamping the FDA
    Agency needs to adopt new tools to do its job in the 21st century.
    July 13, 2007 - PETER PITTS - Policy - Regulatory
  • Worried Sick
    Biotech execs see regulatory burdens as the industry's biggest challenge.
    May 14, 2007 - Policy - Regulatory
  • Is It Safe?
    Drug-approval delays threaten public safety.
    May 08, 2007 - PETER PITTS - Policy - Regulatory
  • Mixing Molecular Metaphors
    Andrew von Eschenbach says the FDA needs to change.
    May 07, 2007 - DANIEL S. LEVINE - Policy - Regulatory
  • Eye on the Street
    The latest news and numbers from Wall Street.
    January 22, 2008 - Business - Markets
  • Eye on the Street
    The latest news and numbers from Wall Street.
    January 22, 2008 - Business - Markets
  • PODCAST: January 2008
    December 31, 2007 - Business - Global Economy
  • VIDEO: The Stem Cell Summit
    Selected sessions from the event held October 2-3, 2007 in Boston, Massachusetts hosted by Genetics Policy Institute, Harvard Stem Cell Institute and Burrill Life Sciences Media Group.
    October 18, 2007 - Business - Finance
  • Simple Math
    Pharma should partner with industry in developing nations to create cost-scaled markets within the world's emerging economies.
    July 21, 2007 - LISA CONTE - Health - Global Health